Guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells
View this resource Bookmark this resource
European Medicines Agency. Committee for Advanced Therapies (CAT). Guideline on Quality, Non-Clinical and Clinical Aspects of Medicinal Products Containing Genetically Modified Cells. 3 November 2020. EMA/CAT/GTWP/671639/2008 Rev. 1
Published by EMA
Non-ClinicalGuidelineQualityClinical AspectsGenetically Modified Cell